Showing results (231-240 of 438) with videos related to
Sort By:
Pageof 44
European Journal of Cancer (Oxford, England : 1990)|March 29, 2017
Autophagy-related polymorphisms predict hypertension in patients with metastatic colorectal cancer treated with FOLFIRI and bevacizumab: Results from TRIBE and FIRE-3 trialsMartin D Berger, Shinichi Yamauchi, Shu Cao, et al.British Journal of Cancer|November 23, 2021
Variant allele frequency in baseline circulating tumour DNA to measure tumour burden and to stratify outcomes in patients with RAS wild-type metastatic colorectal cancer: a translational objective of the Valentino studyPaolo Manca, Salvatore Corallo, Sara Lonardi, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 28, 2020
Microsatellite Instability in Patients With Stage III Colon Cancer Receiving Fluoropyrimidine With or Without Oxaliplatin: An ACCENT Pooled Analysis of 12 Adjuvant TrialsRomain Cohen, Julien Taieb, Jack Fiskum, et al.The Pharmacogenomics Journal|June 22, 2018
Potential role of PIN1 genotypes in predicting benefit from oxaliplatin-based and irinotecan-based treatment in patients with metastatic colorectal cancerMitsukuni Suenaga, Marta Schirripa, Shu Cao, et al.The Oncologist|August 20, 2025
First-line PD-1 +/- CTLA-4 blockade in patients with deficient mismatch repair and/or microsatellite instability-high metastatic colorectal cancerVincenzo Nasca, Gabriele Tinè, Julien Taieb, et al.British Journal of Cancer|August 28, 2025
Primary tumor sidedness and negative hyperselection to modulate anti-EGFR-based maintenance strategies in patients with RAS wild-type metastatic colorectal cancer: individual patient data pooled analysis of two randomized clinical trialsAlexej Ballhausen, Federica Morano, Arndt Stahler, et al.Journal of Personalized Medicine|November 27, 2021
Association of CLDN18 Protein Expression with Clinicopathological Features and Prognosis in Advanced Gastric and Gastroesophageal Junction AdenocarcinomasAntonio Pellino, Stefano Brignola, Erika Riello, et al.The Oncologist|May 10, 2018
Trifluridine/Tipiracil (TAS-102) in Refractory Metastatic Colorectal Cancer: A Multicenter Register in the Frame of the Italian Compassionate Use ProgramChiara Cremolini, Daniele Rossini, Erika Martinelli, et al.British Journal of Cancer|June 26, 2019
Claudin-18 expression in oesophagogastric adenocarcinomas: a tissue microarray study of 523 molecularly profiled casesIrene Coati, Gábor Lotz, Giuseppe Nicolò Fanelli, et al.European Journal of Cancer (Oxford, England : 1990)|February 9, 2019
Phase II randomised study of maintenance treatment with bevacizumab or bevacizumab plus metronomic chemotherapy after first-line induction with FOLFOXIRI plus Bevacizumab for metastatic colorectal cancer patients: the MOMA trialChiara Cremolini, Federica Marmorino, Francesca Bergamo, et al.Pageof 44